View Older Stories View More Recent Stories

May 9, 2024 04:01PM Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results
May 9, 2024 07:00AM Bluejay Therapeutics Secures $182 Million in Series C Financing to Propel Clinical Pipeline
May 8, 2024 08:00AM Jnana Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
May 7, 2024 04:52PM Form SC 13D/A Werewolf Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 6, 2024 05:58PM Form SC 13G Avidity Biosciences, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 6, 2024 08:00AM Sortera Technologies Announces Curt Sacks as Senior Vice President and CFO
May 2, 2024 05:59PM Form SC 13G Zura Bio Ltd Filed by: RA CAPITAL MANAGEMENT, L.P.
May 2, 2024 08:00AM Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update
May 2, 2024 07:08AM Mariana Oncology to be Acquired by Novartis (NVS) to Advance Precision Radiopharmaceuticals to Treat Cancer
May 2, 2024 07:00AM Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer
Apr 30, 2024 04:17PM Form SC 13D/A Aerovate Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 26, 2024 09:38AM Commons Clinic Invests $9.75M in Advanced Spine Surgery Center; Launches Next-Gen Ambulatory Surgical Platform "Theater"
Apr 25, 2024 08:43PM Form SC 13G Protara Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 24, 2024 04:05PM Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
Apr 23, 2024 09:00AM Be Biopharma to Present at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Apr 18, 2024 09:22AM Zura Bio (ZURA) Enters $112.5M Private Placement
Apr 18, 2024 09:22AM Zura Bio Announces Oversubscribed $112.5 Million Private Placement
Apr 16, 2024 08:00AM Asher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials
Apr 15, 2024 04:46PM Form SC 13G Surrozen, Inc./DE Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 12, 2024 06:53PM Form SC 13D/A Eliem Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 12, 2024 04:25PM Form SC 13G Boundless Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 11, 2024 07:56PM Form SC 13G CervoMed Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 11, 2024 04:16PM Form SC 13D/A Acrivon Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 11, 2024 07:00AM Eliem Therapeutics (ELYM) to Acquire Tenet Medicines, Announces Concurrent $120M Private Placement
Apr 11, 2024 07:00AM Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
Apr 10, 2024 07:00AM TORL BioTherapeutics Announces $158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline
Apr 9, 2024 07:01AM Acrivon Therapeutics (ACRV) Announces $130 Million Private Placement Financing
Apr 9, 2024 07:00AM Acrivon Therapeutics Announces $130 Million Private Placement Financing
Apr 8, 2024 12:00PM Adela Presents Data Demonstrating Ability of Tissue-Agnostic MRD Assay to Predict Recurrence in Head & Neck Cancer at the American Association for Cancer Research Annual Meeting 2024
Apr 5, 2024 08:05AM Protara Therapeutics (TARA) Announces $45M Private Placement at $4.15/sh
Apr 5, 2024 08:04AM Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing
Apr 4, 2024 07:05PM Form SC 13G Dyne Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 4, 2024 03:30AM Adcendo ApS to Present Data on its Novel ADC Target uPARAP in Glioblastoma Multiforme at the American Association for Cancer Research Annual Meeting 2024
Apr 3, 2024 08:00AM Obsidian Therapeutics Announces Oversubscribed $160.5 Million Series C Financing to Drive OBX-115 Clinical Development
Apr 3, 2024 06:00AM Diagonal Therapeutics Launches with $128 Million in Financing to Pioneer a New Approach to Discovering and Developing Agonist Antibodies to Tackle the Underlying Causes of Severely Debilitating Diseas
Apr 2, 2024 08:05AM MaxCyte Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines (BCMs)
Apr 1, 2024 07:34PM Form SC 13G SERA PROGNOSTICS, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 1, 2024 08:31AM Surrozen (SRZN) Announces $192.5M Private Placement
Apr 1, 2024 08:30AM Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules
Apr 1, 2024 08:12AM Selux Diagnostics Announces Additional $48 Million in Funding
Apr 1, 2024 08:00AM CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
Apr 1, 2024 07:30AM Leading healthcare fund manager RA Capital launches biotech ETFs
Mar 29, 2024 05:41PM Form SC 13D/A Nkarta, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 29, 2024 04:14PM Form SC 13D/A ARS Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 29, 2024 04:01PM Avalo Reports 2023 Financial Results and Provides Business Updates
Mar 29, 2024 12:55PM Form SC 13G Alto Neuroscience, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 28, 2024 04:21PM Form SC 13D LENZ Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 28, 2024 08:31AM CervoMed (CRVO) Announces Up to $149.4M Private Placement Financing
Mar 28, 2024 08:30AM CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
Mar 27, 2024 04:01PM Avalo Therapuetics (AVTX) Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
View More Recent Stories View Older Stories